Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b00150b1f7cda5606819dae0bff9cee4 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-075 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70571 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-027 |
filingDate |
2006-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88e064d7b3f9b4d091e9b26e73007587 |
publicationDate |
2006-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2006206951-A1 |
titleOfInvention |
GABA B1A receptor disruptions, compositions and methods relating thereto |
abstract |
The present disclosure relates to compositions and methods relating to the characterization, function, and uses of GABA-B1A. Specifically, the present disclosure provides transgenic animals comprising disruptions in GABA-B1A receptors. The present disclosure also provides methods of identifying agents that modulate GABA-B1A, useful models, and potential treatments for various disease states and disease conditions. |
priorityDate |
2001-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |